Finland· FI-REL-REL10069
Ciproxin-Hydrocortison
A hydrocortison und antiinfektiva product containing ciprofloxacin hydrochloride + hydrocortisone, registered in Finland by Novartis Finland Oy. The same ATC class is registered in 6 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Hydrocortison und antiinfektiva is registered in 6 of 19 countries.
Countries holding a registration under ATC S02CA03 (hydrocortison und antiinfektiva), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 3 of them publish a price we can compare per daily dose
Hydrocortison und antiinfektiva · ATC S02CA03
6 / 19 countries
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Switzerlandprice
The record
At a glance
Fimea (Finland)- Active substance
- Ciprofloxacin hydrochloride + Hydrocortisone
- Manufacturer
- Novartis Finland Oy
- Country
- Finland (FI)
- ATC code
- S02CA03
- ATC class
- Hydrocortison und Antiinfektiva
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Hydrocortison und antiinfektiva in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesCIPROAsclemed USA, Inc.
- SwitzerlandCiproxin HC
- SpainCIPROXINA 2 mg/ml + 10 mg/ml GOTAS OTICAS EN SUSPENSIONNovartis Farmaceutica S.A.
- IcelandCifloxNovartis Healthcare A/S
Authorised across Europe · EMA
The same active substance is authorised in 7 EEA countries. Names it is sold under:
- Cyprus · Vioticer
- Denmark · Ciflox
- Estonia · Ciprobay Hc
- Spain · Ciproxina
- Greece · Vioticer
- Iceland · Ciflox
- Malta · Ciproxin Hc Otic
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fd7a7799-cac1-4a73-82ce-6bb2c23a8a5a GET /v1/drugs/fd7a7799-cac1-4a73-82ce-6bb2c23a8a5a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": null,
"form": "korvatipat, suspensio",
"route": "Korvaan",
"ddd_unit": null,
"strength": "2 mg/ml + 10 mg/ml",
"atc_label": "hydrokortisoni ja mikrobilääkkeet",
"ma_number": "13316",
"auth_status": "Myyntilupa myönnetty",
"eu_ma_number": null,
"fimea_rel_id": "REL10069",
"authorised_at": "1998-08-31"
}See everything about hydrocortison und antiinfektiva.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.